| Message | Subject | Recs | Date/Time (ET) |
| With no underground caverns to store nat gas in New England, pipeline capacity b | Biotech Valuation | 1 | 02/16/2013 01:59:59 PM |
| [i]But before we go there, the low-hanging fruit is replacing oil heating with n | Biotech Valuation | | 02/15/2013 11:45:37 PM |
| Since the energy demand is not skyrocketing but rather increasing gradually (and | Biotech Valuation | 2 | 01/21/2013 10:41:41 PM |
| Yes, most definitely - at least regarding the hyperinflation. Costs of borrowing | Biotech Valuation | | 01/07/2013 08:48:27 PM |
| Actually, Weimar Republic didn't borrow/issue bonds, at least in the amount remo | Biotech Valuation | | 01/06/2013 11:24:04 PM |
| We are quite competitive with the existing plant v. similar plant elsewhere. If | Biotech Valuation | | 09/17/2012 10:58:23 AM |
| We don't necessarily disagree. GINI index is a function not only of taxation sch | Biotech Valuation | | 09/16/2012 01:49:10 PM |
| VAT (when it is rebated on the exports) serves this purpose reasonably cleanly, | Biotech Valuation | | 09/15/2012 01:41:47 PM |
| The Danish tax info is pretty surprising - their system is way flatter than what | Biotech Valuation | | 09/15/2012 01:35:15 PM |
| [i]I don't believe the proposal I read about included any sort of fed guarantee | Biotech Valuation | | 04/18/2012 10:23:30 PM |
| [i]The claim was that the interest rate subsidy was substantially cheaper for th | Biotech Valuation | | 04/18/2012 12:01:55 AM |
| Rich muni investors will demand and receive higher yield if their bonds become t | Biotech Valuation | | 04/17/2012 10:32:23 PM |
| If there is no export duty on the diesel produced by the hypothetical new Shell | Biotech Valuation | 1 | 04/08/2012 09:37:43 PM |
| There are some claims that Methanol to Gasoline process (MTG) is better for the | Biotech Valuation | | 03/03/2012 10:15:58 PM |
| [i]cost over $18 billion for for about 250,000 BOE/day [/i]
[i]
[/i]
Basicall | Biotech Valuation | | 03/03/2012 09:45:45 PM |
| [i]At some point gas-to-liquids becomes viable, especially given low long-term i | Biotech Valuation | | 03/03/2012 04:38:09 PM |
| Assuming Wikipedia statement that giant miscanthus can produce up to 20 metric t | Biotech Valuation | 1 | 02/27/2012 11:50:55 PM |
| Making muni bonds taxable will make the [fairly regressive] property tax payers | Biotech Valuation | | 12/11/2011 03:25:16 PM |
| I am somewhat reluctant to continue this conversation that strays away from the | Biotech Valuation | 1 | 12/11/2011 12:27:41 AM |
| Well, the six Waltons (who technically reside in Arkansas) are just useless heir | Biotech Valuation | 5 | 12/10/2011 06:14:21 PM |
| Rick, warmest congratulations! | momo-T/FIF | | 11/09/2011 11:17:49 PM |
| SNMX develops molecules affecting human receptors (in their case, taste) based o | 2011 Biotech Charity Contest | 2 | 07/03/2011 04:53:35 PM |
| <i>But there are plenty of homes in the Boston metropolitan area that use oil de | Biotech Valuation | | 03/21/2011 07:55:10 PM |
| Infrastructure (or rather an absence of it) is the main obstacle in CNG use as t | Biotech Valuation | | 03/20/2011 10:00:05 PM |
| <b>Cancer Costs to Rise as Aging U.S. Population Lifts Tumor Count</b>
By Miche | Biotech Valuation | 1 | 01/12/2011 11:19:31 PM |
| In a "classic" economy private spending has a higher multiplier, that's for sure | Biotech Valuation | 1 | 12/01/2010 09:52:37 PM |
| There are only two ways to eliminate the trade deficit (aggravated by the fact t | Biotech Valuation | | 07/06/2010 09:57:47 PM |
| <i>We can materially reduce the foreign trade deficit by using natural gas for t | Biotech Valuation | 1 | 07/05/2010 10:13:57 PM |
| Decline of the domestic manufacturing is joined at the hip with the huge foreign | Biotech Valuation | 3 | 07/05/2010 01:03:00 PM |
| I wonder if Coke assuming they see the value in the concept will now go to the " | Senomys(SNMX)- A Taste for Success!!! | | 06/24/2010 11:21:51 PM |
| I personally know a back room guy (who actually IS a former physicist from Russi | Biotech Valuation | 1 | 01/26/2010 09:06:27 PM |
| I am not sure this is the bioavailability effect per se: even 80-120% is less of | Biotech Valuation | 1 | 12/19/2009 09:49:12 PM |
| I wonder if this issue (minor impurities in generic APIs v. the original being b | Biotech Valuation | 1 | 12/08/2009 09:51:24 PM |
| HFT is certainly a zero-sum game so it obviously d | momo-T/FIF | | 11/12/2009 10:48:30 PM |
| <i> However, the high inter- and intraindividual variability in sCT exposure dem | Biotech Valuation | | 10/16/2009 12:01:54 AM |
| <i>If so, why don't they practice where they can make 4x the income?</i>
Besi | Biotech Valuation | | 09/06/2009 01:58:11 PM |
| BBH is supposed to track ^BTK, but it only includes half of the components (and | Biotech Valuation | | 08/11/2009 08:58:04 PM |
| Rail Freight Traffic Down in June
WASHINGTON, July 2, 2009 — The Association | Biotech Valuation | 1 | 07/08/2009 10:08:50 PM |
| KERX went up about 40% in AH w/good volume on Friday on kidney cancer perifosine | biotech fireworks | | 05/31/2009 03:45:56 PM |
| Rick,
My sincerest condolences.
T. | momo-T/FIF | | 05/18/2009 07:52:20 PM |
| Pharmas lack science expertise at the top
By Andrew Jack in London
Publishe | Biotech Valuation | 1 | 04/06/2009 12:10:42 AM |
| Does anyone remember what was the reason FDA didn't want ARNA to run a combo tri | Arena Pharmaceuticals (ARNA) | | 03/30/2009 08:50:26 PM |
| Boston and San Francisco (where the expenses were rising slowly) are definitely | Biotech Valuation | | 03/26/2009 08:19:07 PM |
| For extremely high levels of employee compensation (millions $$), as opposed to | Biotech Valuation | 1 | 03/22/2009 11:04:04 PM |
| Looks to me that the fear of FDA not approving because of the absence of any com | biotech firesales | | 03/16/2009 07:43:35 PM |
| In the current environment, and with the changes in NLY business model in the la | Biotech Valuation | 1 | 02/04/2009 10:38:26 PM |
| This is an editorial from OPRD (Trevor Laird is an editor-in-chief and one of th | Biotech Valuation | 1 | 02/02/2009 09:48:06 PM |
| In line with the thread topic, I will only talk about #1 on the list. The proble | Biotech Valuation | 2 | 02/01/2009 07:16:40 PM |
| http://www.xconomy.com/boston/2009/01/15/how-to-survive-the-downturn-five-questi | Biotech Valuation | | 01/15/2009 10:04:52 PM |
| LXRX is a "super-repeat" - about halved in 2 days on no news and mildly bigger t | biotech firesales | | 10/07/2008 08:22:53 PM |
Copyright © 1995-2013 Knight Sac Media. All rights reserved.
